MARKET

AXDX

AXDX

Accelerate
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.24
+0.02
+0.18%
Closed 16:00 09/21 EDT
OPEN
10.99
PREV CLOSE
11.22
HIGH
11.32
LOW
10.51
VOLUME
200.32K
TURNOVER
--
52 WEEK HIGH
21.71
52 WEEK LOW
4.530
MARKET CAP
633.43M
P/E (TTM)
-7.4918
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Accelerate Diagnostics Announces New FDA Clearance for Accelerate PhenoTest® Improvements
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system, which improve performance and expand the system's antimicrobial susceptibility testing
PR Newswire · 5d ago
Accelerate Diagnostics Announces New FDA Clearance For Accelerate PhenoTest Improvements
Accelerate Diagnostics Announces New FDA Clearance for Accelerate PhenoTest® Improvements TUCSON, Ariz., Sept. 16, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the
Benzinga · 5d ago
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG Antibody Tests
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the individual BioCheck SARS-CoV-2 IgM Test
PR Newswire · 09/10 14:00
TGT, NAK among premarket gainers
Momenta Pharmaceuticals (MNTA) +69% on J&J acquisition.Hudson (HUD) +49% on take over offer of $7.70/share from its controlling shareholder.LightInTheBox Holding (LITB) +38% on Q2 results.Teligent (TLGT) +36% on Q2 results.Immunovant (IMVT) +20%.SilverSun Technologies (SSNT)
Seekingalpha · 08/19 12:12
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) * Avenue Therapeutics Inc (NASDAQ: ATXI) * Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) * DarioHealth Corp (NASDAQ: DRIO) * iTeos Therapeutics Inc (NASDAQ: ITOS) * Merit Medical Systems, Inc. (NASDAQ: MMSI) * Natera Inc (NASDAQ: NTRA
Benzinga · 08/19 11:32
Accelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 Testing
SmarterAnalyst · 08/19 08:58
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BioCheck SARS-CoV-2 IgM and IgG Combo
PR Newswire · 08/18 21:15
Accelerate Diagnostics up 13% on FDA emergency use nod for COVID-19 test
Accelerate Diagnostics (AXDX) announces FDA emergency use authorization of privately held BioCheck's SARS-CoV-2 IgM and IgG Combo Test and its fully automated MS-Fast instrument.Accelerate will commercialize the chemiluminescence test and
Seekingalpha · 08/18 20:39
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AXDX stock price target is 19.00 with a high estimate of 20.00 and a low estimate of 18.00.
EPS
Institutional Holdings
Institutions: 167
Institutional Holdings: 30.68M
% Owned: 54.44%
Shares Outstanding: 56.36M
TypeInstitutionsShares
Increased
43
1.61M
New
32
397.07K
Decreased
22
2.45M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-1.41%
Healthcare Equipment & Supplies
-1.43%
Key Executives
Chairman/Independent Director
John Patience
Chief Executive Officer/Chief Operating Officer/Director
John Phillips
Chief Financial Officer
Steve Reichling
Senior Vice President
Ron Price
Other
Nedal Safwat
Independent Director
Thomas Brown
Independent Director
Tom Brown
Independent Director
Roland Diggelmann
Independent Director
Louise Francesconi
Independent Director
Mark Miller
Independent Director
Jack Schuler
Independent Director
Matthew Strobeck
Independent Director
Frank ten Brink
Independent Director
Charles Watts
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More

Analyst Price Target

The average AXDX stock price target is 19.00 with a high estimate of 20.00 and a low estimate of 18.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AXDX
Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Accelerate Diagnostics Inc stock information, including NASDAQ:AXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXDX stock methods without spending real money on the virtual paper trading platform.